PTO Rule Opponents Look Hopefully To GSK Case

Law360, New York (October 29, 2007, 12:00 AM EDT) -- As the U.S. Patent and Trademark Office prepares to implement its set of hotly contested new rules on Thursday, opponents are eagerly awaiting a hearing on GlaxoSmithKline's motion for an injunction, hoping that it will succeed in stopping the change for now at least.

“My clients and I are certainly rooting for the good guys in this one,” said Michael Gollin, a partner in the technology division of Venable LLP's intellectual property practice. “I think it's the best shot that can be made to make some...
To view the full article, register now.